Ginkgo Bioworks Target price 2026 - Analyst rating & recommendation
Ginkgo Bioworks Classifications & Recommendation
Ginkgo Bioworks Price Target
| Target Price | $9.18 |
| Price | $10.66 |
| Deviation |
13.88%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Ginkgo Bioworks 2027 .
The average Ginkgo Bioworks target price is $9.18.
This is
13.88%
register free of charge
$9.45
11.35%
register free of charge
$9.09
14.73%
register free of charge
|
|
| A rating was issued by 10 analysts: 0 Analysts recommend Ginkgo Bioworks to buy, 3 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ginkgo Bioworks stock has an average upside potential 2027 of
13.88%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 170.16 | 85.88 |
| 25.05% | 49.53% | |
| EBITDA Margin | -147.44% | -202.16% |
| 20.35% | 37.11% | |
| Net Margin | -183.80% | -250.99% |
| 23.71% | 36.55% |
4 Analysts have issued a sales forecast Ginkgo Bioworks 2026 . The average Ginkgo Bioworks sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Ginkgo Bioworks EBITDA forecast 2026. The average Ginkgo Bioworks EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Ginkgo Bioworks Analysts have issued a net profit forecast 2026. The average Ginkgo Bioworks net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.64 | -3.38 |
| 46.49% | 40.07% | |
| P/E | negative | |
| EV/Sales | 4.84 |
4 Analysts have issued a Ginkgo Bioworks forecast for earnings per share. The average Ginkgo Bioworks EPS is
This results in the following potential growth metrics and future valuations:
Ginkgo Bioworks...
Current Ginkgo Bioworks Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Sep 04 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Mar 12 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jan 08 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 25 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 20 2024 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 23 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 04 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Mar 12 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jan 08 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 25 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 20 2024 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 23 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
